Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
South Plains Oncology Consortium
South Plains Oncology Consortium
West China Hospital
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Samsung Medical Center
Shenzhen Second People's Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Neotropix
Gustave Roussy, Cancer Campus, Grand Paris